USTEKINUMAB-TTWE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 15 adverse event reports in the FDA FAERS database where USTEKINUMAB-TTWE was used for Psoriasis.
Most Reported Side Effects for USTEKINUMAB-TTWE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Crohn's disease | 8 | 9.6% | 0 | 1 |
| Off label use | 8 | 9.6% | 0 | 3 |
| Fatigue | 7 | 8.4% | 0 | 0 |
| Drug ineffective | 6 | 7.2% | 0 | 2 |
| Lower respiratory tract infection | 6 | 7.2% | 0 | 2 |
| Dyspnoea | 5 | 6.0% | 0 | 2 |
| Headache | 5 | 6.0% | 0 | 0 |
| Infection | 5 | 6.0% | 0 | 4 |
| Pruritus | 5 | 6.0% | 0 | 1 |
Other Indications for USTEKINUMAB-TTWE
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)